✨Highlights #1 of #ASCO24:.- Grateful to @ConquerCancerFd for the MSR award supporting my rotation w/ Dr. Okimoto at @UCSF where I learned more about bench to bedside/clinical trials & wrote a review!.- Presented my @BUMedicine work w/ Dr. Ko & Dr. Weinberg @ the Abstract Forum!

RT @hammy_oh: I am excited to present our new study out in @NatureMedicine where we discover a novel synaptic protein biomarker to predict….

Excited to share our review that examine key influencers of medical mistrust, its impact on cancer care utilization, and interventions! Thankful for the guidance of amazing @BUMedicine leaders, @NaomiKoMD @doc_kgb @karinapverma @BrimhallKim

His match day on our four year anniversary. ❤️ His work ethic is inspiring, and I am so grateful to have witnessed his growth these past four years! #internalmedicine #Match2025 #MatchDay2025

RT @Kevin_Reyes650: Excited to share that I will be staying at UCSF for internal medicine residency! I am so grateful for my loved ones who….

RT @jpurabryant: A dream come true! I matched at @ColumbiaMed for Internal Medicine in the presence of my family and closest friends! I pra….

RT @jpurabryant: 🙏🏽Wow! Thank you so much for everyone who prayed over me and supported my journey. ✅I am officially employed - can’t wai….

Very grateful for the opportunity to be a 2025 @APOSHQ Health Equity Scholar & relationships built at this conference! Such meaningful, inspiring work done by this community FOR the community. Excited for the year to come w/ my mentor @KellyIrwin_MD & cohort includ @AriennePatano

✨Highlight #2 of #ASCO24.- 👏Kevin & @BryanHLau presenting at the Annual Meeting & Abstract Forum!.- Meeting fellow med students 🇵🇭🌎 .- Learning from great faculty via @ConquerCancerFd Diversity in Onc Meet&Greet, UCSF Global Cancer dinner like @AnaVManana & @s_brond! Thankful!

RT @AnaVManana: Love sharing last night with our wonderful group of trainees & mentees, international collaborators, and @UCSFCancer facul….

RT @jpurabryant: 🤓 My Day 2 #ASCO24 highlights:. - 🔬Presented at the Med Student & Resident Abstract Forum. - 🤩Diversity in Oncology meet a….

My MSR project was published today! Thank you @ConquerCancerFd for the opportunity & to my mentor Dr. Ross Okimoto’s support. Excited to build on prior work at @UCSF: molecular & clinical overview of CIC-rearranged tumors w/ rationale for future therapies

RT @ConquerCancerFd: Congratulations to this year's class of Conquer Cancer Grant and Award recipients! We can't wait to celebrate with you….

RT @Kevin_Reyes650: Check out our paper on salvage treatment post BCMA CAR-T Relapse for patients with multiple myeloma! Grateful for the U….

RT @hammy_oh: I am thrilled to present our new study out in @Nature where we measure aging at organ-level resolution in living people with….

RT @wysscoray: excited to share an in-depth review of aging clocks or-more appropriate-methods to estimate biological age .

RT @JCI_insight: WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma: @UCSFMedicine .#O….

RT @nickthomasmed: 🚨New in @JCI_insight🚨:.Our Okimoto lab group has identified WEE1 as a potential therapeutic target in a rare form of sar….

Excited to share our findings from the Okimoto lab at UCSF and my first co-first author pub w/ @nickthomasmed! We identified Wee1 inhibition as a therapeutic target in CIC-DUX4 sarcomas which has poor clinical outcomes and current ineffective therapies.

WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma. . Super grateful to have had the opportunity to work on this project alongside @nickthomasmed in Dr. Okimoto's lab!.